Buchler GmbH
  • Products
    • Active Pharmaceutical Ingredients
    • Asymmetric Synthesis
      • Chiral Building Blocks
      • Chiral Phase Transfer Catalysts (PTCs)
      • Chiral Screening Kit
      • Enantioselective Organocatalysts
      • Racemic Resolution
    • Food Ingredients
    • Product Overview
  • Chiral Catalyst Search
  • Contact
  • About
    • Certificates
    • Company Policy
    • Former Buchler Company Managers
    • Galleries
      • Gallery current production and storage
      • Gallery Laboratory
      • Gallery Historical Production
    • History of Buchler
  • Career
Select Page

Michael Addition, (E)-1,3-difluoro-5-(2-nitrovinyl)benzene, (fluoro(nitro)methyl)benzene, 1,3-difluoro-5-((1R,2S)-1-fluoro-1,3-dinitro-1-phenylpropan-2-yl)benzene, (2S,3R)-2-[[[[3,5-bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N-(8α,9S)-cinchonan-9-yl-3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-butanamide, Cinchonidine Derivative

by werner@buchler-gmbh.com | Oct 13, 2023

Michael Addition, 1,3-dicarbonyl compounds, β-fluoroalkyl-α-nitroalkenes, substituted 2-(2-nitroethyl)-propane-1,3-dione, (8α,9R)-Cinchonan-6′,9-diol-9-benzoate, Cupreine Derivative

by werner@buchler-gmbh.com | Sep 15, 2023

Sulfenylation, azlactones, N-(sulfanyl) succinimides, α-sulfenylated azlactones, 3-[[3,5-bis(trifluoromethyl)phenyl]amino]-4-[[(8α,9S)-6′-methoxycinchonan-9-yl]amino]-3-Cyclobutene-1,2-dione, Quinine Derivative

by Anna-Lena Hartmann | Jul 17, 2023

Trifluoromethylthiolation, 3-substituted oxindoles, [(trifluoromethyl)thio]-silver, (S)-5-chloro-3-(4-chlorophenyl)-3-((trifluoromethyl)thio)indolin-2-one, 1,3,5-Trichloroisocyanuric acid, (9S,9′′S)-9,9′′-[(2,5-diphenyl-4,6-pyrimidinediyl)bis(oxy)]bis[10,11-dihydro-6′-methoxy-cinchonan], Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jul 6, 2023

Chlorination, substituted 1-(1-phenylvinyl)cyclobutan-1-ol, 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione, substituted (S)-2-(chloromethyl)-2-phenylcyclopentan-1-one, 1,4-Bis(9-O-dihydroquinidinyl)phthalazine, Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jul 5, 2023

« Older Entries
Next Entries »

Glossary

Impressum / Legal Notice

Code of Conduct

Hinweisgebersystem / Whistleblowing System

Allgemeine Geschäfts-bedingungen / General Terms and Conditions

Datenschutzhinweise / Data Protection Information

Contact

My Account
  • Follow
  • Follow

All Rights Reserved by Buchler GmbH